Clinical Trial Update: A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency [NA]

View source ↗

Summary

A completed clinical trial evaluating a test to predict drug-induced hemolysis in individuals with glucose-6-phosphate dehydrogenase deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Favism
• Glucose-6-phosphate Dehydrogenase Deficiency

Snippet

Sponsor: Walter Reed Army Institute of Research (WRAIR) | Conditions: Glucosephosphate Dehydrogenase Deficiency, Favism | NA | Status: COMPLETED